Dynavax Technologies Stock (NASDAQ: DVAX)

Dynavax Technologies (NASDAQ:DVAX) Stock, Unusual Options

Dynavax Technologies

Dynavax Technologies Corporation - Common Stock

Overview

News

Earnings

Options

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Comments

Dynavax Technologies Unusual Options